|
|
Pharma-Industry News
| |
|
Get A 700+ Credit Score - Sponsored Link
|
|
Former Keys jail guard gets 16 years: Hernandez sentenced for drug conspiracy
|
|
SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
|
|
Kingdom OKs Glaxo vaccine
|
|
SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
|
|
SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
|
|
Quintiles Announces Clinical Pharmacology Alliance with AstraZeneca
|
|
UT Southwestern Researchers Use Drug-Radiation Combo to Eradicate Lung Cancer
|
|
Aureus Pharma Extends its Knowledge Database Agreement with Sanofi-Aventis R&D
|
|
Pharma Outsourcing, 8-9 April 2010, Munich, Germany
|
|
Impedance-Based Measurement of GPCR Modulators in Drug Discovery â" Characterization of Signalling Pathways in Recombinant and Non-Recombinant Cells
|
|
SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
|
|
Biopharmaceutical Companies Generating Gains: ZGEN, INO - sourced PicksThatMove.com
|
|
SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
|
|
SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
|
|
The creation of a new niche specialty pharmaceutical company focused on rare diseases - with ...
|
|
SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
|
|
Virginia Man Sues Walmart and Drug Company Over 2-Day Erection
|
|
Pharma companies deny reports on spurious drugs
|
|
Elan, Biogen change Tysabri
|
|
SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
|
|
Johnson & Johnson to cut 7,000 jobs
|
|
Johnson & Johnson-Shampoo-Baby Shampoo (detangling formula) (3.9 lippies, 12 reviews)
|
|
GlaxoSmithKline and XenoPort Announce Extension of GSK1838262 (XP13512) FDA Review Date to February 9, 2010
|
|
RXi Pharmaceuticals Appoints Noah D. Beerman as CEO
|
|
Plethico Pharmaceuticals introduces new Natrol 'Immune Boost'
|
|
China Pharma Holdings Inc. (NYSE AMEX:CPHI) to Release Q3 2009 Earnings November 12
|
|
Hemispherx Biopharma Announce Two Prong Chronic Fatigue System Mission
|
|
Helix Biopharma Finish 120 Patient Enrollment for Phase II Trial of Topical Interferon Alpha-2b for Treatment of Ano-Genital Warts
|
|
GlaxoSmithKline and XenoPort Announce Extension of GSK1838262 (XP13512) FDA Review Date to February 9, 2010
|
|
Is Your Doctor’s Continuing Ed Funded by Pharma?
|
|
